Inclusive of all taxes
Ceftriaxone Sodium for Injection 125mg is a potent third-generation cephalosporin antibiotic formulated as a dry powder for injection. Designed for parenteral use, either intravenously or intramuscularly, this antibiotic offers broad-spectrum efficacy against a variety of Gram-positive and Gram-negative bacterial pathogens. Specifically effective in treating serious infections such as respiratory tract infections, urinary tract infections, skin and soft tissue infections, septicemia, and meningitis, Ceftriaxone Sodium disrupts bacterial cell wall synthesis, leading to bacterial cell lysis and eradication. Its convenient 125 mg dosage makes it ideal for clinical and hospital settings where accurate dosing and reliable antimicrobial action are critical. The product is sterile, ensuring safe administration to patients, and it supports targeted therapy in complex bacterial infections.
Key Features
| Features | Description |
|---|---|
| Form | Sterile dry powder for injection |
| Dosage Strength | 125 mg Ceftriaxone Sodium per vial |
| Administration Route | Intravenous (IV) or Intramuscular (IM) injection |
| Antimicrobial Spectrum | Broad-spectrum activity against Gram-positive and Gram-negative bacteria |
| Mechanism of Action | Inhibits bacterial cell wall synthesis causing cell lysis |
| Sterility | Sterile preparation suitable for parenteral use |
| Packaging | Single-dose vial to prevent contamination |
| Storage | Store below 25°C in a dry place, protect from light |
| Attributes | Description |
|---|---|
| Active Ingredient | Ceftriaxone Sodium |
| Strength | 125 mg per vial |
| Physical State | Dry powder |
| Reconstitution | Reconstituted with sterile water or appropriate diluent before administration |
| Shelf Life | Typically 24 months from manufacturing date |
| Packaging Type | Glass vial with rubber stopper |
| Indications | Treatment of bacterial infections including respiratory tract infections, UTIs, skin infections, meningitis, and septicemia |
| Pharmacological Class | Third-generation cephalosporin antibiotic |
| Route of Administration | Intravenous (IV) or Intramuscular (IM) |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Ceftriaxone Sodium for Injection 125 mg is often used in pediatric treatments but dosage and suitability must be determined by a qualified healthcare professional based on patient weight and infection severity.
Sterile water for injection or permissible diluents such as 0.9% Sodium Chloride Injection or 5% Dextrose Injection are recommended for reconstituting the dry powder before administration.
Yes, once reconstituted, Ceftriaxone Sodium injection can be further diluted with compatible intravenous fluids for continuous IV infusion as per clinical guidelines.
Store the dry powder vials below 25°C in a dry place, protected from light, and do not freeze to maintain product integrity.
While Ceftriaxone has broad-spectrum activity, resistance profiles vary; susceptibility testing is recommended to confirm effectiveness against strains in specific clinical cases.
Ceftriaxone Sodium for Injection 125 mg is a third-generation cephalosporin antibiotic used to treat various bacterial infections. It is known for its broad-spectrum activity against both Gram-positive and Gram-negative bacteria.
Key Features:
Form: Dry powder for injection.
Strength: 125 mg of Ceftriaxone Sodium.
Route of Administration: Intravenous (IV) or intramuscular (IM).
Mechanism of Action: Ceftriaxone works by inhibiting bacterial cell wall synthesis, which leads to cell lysis and death.
Inclusive of all taxes
You Save: 0
